GRP
TGTX icon

Global Retirement Partners’s TG Therapeutics TGTX Stock Holding History

Global Retirement Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.19K Sell
107
-265
-71% -$8.65K ﹤0.01% 3578
2025
Q3 		$13.4K Buy
372
+265
+248% +$8.73K ﹤0.01% 2573
2025
Q2 		$3.85K Buy
+107
New +$3.98K ﹤0.01% 3004
2024
Q4 		$3.01K Sell
100
-500
-83% -$14.3K ﹤0.01% 2919
2024
Q3 		$14K Buy
+600
New +$13.1K ﹤0.01% 2157
2024
Q1 		– Sell
-828
Closed -$12.6K – 3479
2023
Q4 		$12.6K Buy
+828
New +$9.62K ﹤0.01% 1968

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Global Retirement Partners's TGTX Position: Q4 2025 in Review

Global Retirement Partners reduced its TG Therapeutics (TGTX) stake by 71% in Q4 2025, selling an estimated $8.65K and leaving 107 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3578.

Global Retirement Partners first reported a position in TGTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $14K in Q3 2024. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Global Retirement Partners held 107 shares of TG Therapeutics worth $3.19K as of Q4 2025.
  • Global Retirement Partners sold 265 TG Therapeutics shares in Q4 2025, an estimated $8.65K.
  • TG Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3578 holding.
  • Global Retirement Partners first reported a position in TG Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • Global Retirement Partners's TG Therapeutics position peaked at $14K in Q3 2024.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.